
Alan Penn & Associates Inc (AKA: APA Inc~Penn Diagnostics) Profile last edited on: 2/20/23
CAGE: 46J82
UEI: GJJMTLUFDK77
Business Identifier: Diagnostic feature analysis methods and systems Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 08
County: Montgomery
Congr. District: 08
County: Montgomery
Public Profile
Alan Penn & Associates, Inc. (APA, Inc.) develops diagnostic feature analysis methods and systems that meet the needs of the medical, commercial and industrial communities. The technology underlying APA, Inc. products is an improved method of characterizing the texture of image and signal data. Texture analysis is used in a variety of fields. An important texture characterization is "fractal dimension" or "fd." Standard fd algorithms are effective only when applied to large data sets; when applied to small data sets, such as small or coarsely digitized images, these methods are unreliable. The companyâs underlying technology is a method of obtaining reliable fd measurements of small data sets. Primary applications lie in the fields of MRI and mammography. The firm provides training solutions and computer decision support systems to improve the early detection and diagnosis of breast cancer. The technology underlying APA's products is an improved method of characterizing the texture of image and signal data. The technology is applicable to a variety of other medical applications in which it is necessary to discriminate growth patterns likely to lead to complications (e.g., coronary plaque), or are likely to lead to successful drug therapy (bacterial growth colonies). The technology is also applicable to non-medical applications, where there is a need for low-resolution, non-destructive imaging (e.g., industrial MRI), or analysis of small regions-of-interest (e.g., bonding or plating surface)
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2015 | 2 | NIH | $1,668,248 | |
Project Title: Novel Diffusion Tensor Imaging CAD for Breast Cancer | ||||
2008 | 1 | NIH | $100,058 | |
Project Title: Add-On Module For Oncad For Diagnosing Infiltrating Lobular Carcinoma | ||||
2005 | 2 | NIH | $2,018,172 | |
Project Title: Statistical Surface Fractal Analyzer Of Breast Cancer | ||||
2000 | 2 | NIH | $798,461 | |
Project Title: Fractal Dimension Features For MRI Breast Mass Analysis | ||||
1998 | 1 | NIH | $99,996 | |
Project Title: Fractal Features For Diagnosing Mammographic Masses |
Key People / Management
Alan I Penn -- President
Scott Thompson
Scott Thompson
Company News
There are no news available.